Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Return on Capital Employed (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Return on Capital Employed for 12 consecutive years, with 0.3% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 26.0% to 0.3% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.3% through Dec 2025, up 26.0% year-over-year, with the annual reading at 0.36% for FY2025, 38.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.3% at Madrigal Pharmaceuticals, up from 0.39% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.3% in Q4 2025, with the low at 3.08% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 1.11%, with a median of 0.93% recorded in 2021.
  • The sharpest move saw Return on Capital Employed tumbled -212bps in 2022, then soared 144bps in 2024.
  • Over 5 years, Return on Capital Employed stood at 1.14% in 2021, then crashed by -78bps to 2.03% in 2022, then skyrocketed by 42bps to 1.19% in 2023, then soared by 53bps to 0.56% in 2024, then surged by 46bps to 0.3% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.3%, 0.39%, and 0.38% for Q4 2025, Q3 2025, and Q2 2025 respectively.